oxybutynin Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
COFEPRIS, INVIMA
Manufacturer #2261

The company researches to develop and provide top-quality products and technological development to improve health and quality of life. The company has been committed for more than 100 years and they are constantly evolving with the ever-changing market and staying in forefront of modern pharmacopeia.

Manufacturer usually replies in 4 days

Oxybutynin is a medication used to treat overactive bladder. Suppliers market it as oxybutynin oral tablets, transdermal patches, topical gels and it is available as immediate and delayed-release formulations. The drug was first approved for medical use in 1975, and by now has reached widespread use, with over 6 million prescriptions registered yearly in the U.S. alone. Multiple manufacturing companies and drug vendors populate the global oxybutynin market, including major suppliers such as Sanofi-Aventis, Mylan, Accord Healthcare, and many others. Suppliers market both generic and trade name oxybutynin medications. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 60 (5mg) tablets of oxybutynin fall into an approximate range of 7.50 EUR to 10.00 EUR.